Cargando…
An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580046/ https://www.ncbi.nlm.nih.gov/pubmed/22991210 http://dx.doi.org/10.1002/jbmr.1758 |
_version_ | 1782260200015659008 |
---|---|
author | Nshimyumukiza, Léon Durand, Audrey Gagnon, Mathieu Douville, Xavier Morin, Suzanne Lindsay, Carmen Duplantie, Julie Gagné, Christian Jean, Sonia Giguère, Yves Dodin, Sylvie Rousseau, François Reinharz, Daniel |
author_facet | Nshimyumukiza, Léon Durand, Audrey Gagnon, Mathieu Douville, Xavier Morin, Suzanne Lindsay, Carmen Duplantie, Julie Gagné, Christian Jean, Sonia Giguère, Yves Dodin, Sylvie Rousseau, François Reinharz, Daniel |
author_sort | Nshimyumukiza, Léon |
collection | PubMed |
description | A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings. |
format | Online Article Text |
id | pubmed-3580046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Wiley Subscription Services, Inc., A Wiley Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-35800462013-02-25 An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures Nshimyumukiza, Léon Durand, Audrey Gagnon, Mathieu Douville, Xavier Morin, Suzanne Lindsay, Carmen Duplantie, Julie Gagné, Christian Jean, Sonia Giguère, Yves Dodin, Sylvie Rousseau, François Reinharz, Daniel J Bone Miner Res Original Articles A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings. Wiley Subscription Services, Inc., A Wiley Company 2013-02 /pmc/articles/PMC3580046/ /pubmed/22991210 http://dx.doi.org/10.1002/jbmr.1758 Text en Copyright © 2013 American Society for Bone and Mineral Research http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Articles Nshimyumukiza, Léon Durand, Audrey Gagnon, Mathieu Douville, Xavier Morin, Suzanne Lindsay, Carmen Duplantie, Julie Gagné, Christian Jean, Sonia Giguère, Yves Dodin, Sylvie Rousseau, François Reinharz, Daniel An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
title | An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
title_full | An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
title_fullStr | An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
title_full_unstemmed | An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
title_short | An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
title_sort | economic evaluation: simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580046/ https://www.ncbi.nlm.nih.gov/pubmed/22991210 http://dx.doi.org/10.1002/jbmr.1758 |
work_keys_str_mv | AT nshimyumukizaleon aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT durandaudrey aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT gagnonmathieu aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT douvillexavier aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT morinsuzanne aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT lindsaycarmen aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT duplantiejulie aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT gagnechristian aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT jeansonia aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT giguereyves aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT dodinsylvie aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT rousseaufrancois aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT reinharzdaniel aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT nshimyumukizaleon economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT durandaudrey economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT gagnonmathieu economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT douvillexavier economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT morinsuzanne economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT lindsaycarmen economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT duplantiejulie economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT gagnechristian economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT jeansonia economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT giguereyves economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT dodinsylvie economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT rousseaufrancois economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures AT reinharzdaniel economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures |